Search

Sabiha Naim Qazi

Examiner (ID: 14019, Phone: (571)272-0622 , Office: P/1621 )

Most Active Art Unit
1616
Art Unit(s)
1621, 1611, 1627, 1202, 1616, 1612, 1629, 1628
Total Applications
2032
Issued Applications
930
Pending Applications
195
Abandoned Applications
909

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5666664 [patent_doc_number] => 20060172014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Treatment of lung cancer with active vitamin D compounds in combination with other treatments' [patent_app_type] => utility [patent_app_number] => 11/298927 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19110 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172014.pdf [firstpage_image] =>[orig_patent_app_number] => 11298927 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/298927
Treatment of lung cancer with active vitamin D compounds in combination with other treatments Dec 11, 2005 Abandoned
Array ( [id] => 5672020 [patent_doc_number] => 20060177374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments' [patent_app_type] => utility [patent_app_number] => 11/298931 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20107 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177374.pdf [firstpage_image] =>[orig_patent_app_number] => 11298931 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/298931
Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments Dec 11, 2005 Abandoned
Array ( [id] => 5672996 [patent_doc_number] => 20060178351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents' [patent_app_type] => utility [patent_app_number] => 11/298989 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26153 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178351.pdf [firstpage_image] =>[orig_patent_app_number] => 11298989 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/298989
Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents Dec 11, 2005 Abandoned
Array ( [id] => 5649756 [patent_doc_number] => 20060135491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Vitamin D3 analog useful for the treatment of osteoporosis' [patent_app_type] => utility [patent_app_number] => 11/295007 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14845 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135491.pdf [firstpage_image] =>[orig_patent_app_number] => 11295007 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/295007
Vitamin D3 analog useful for the treatment of osteoporosis Dec 5, 2005 Abandoned
Array ( [id] => 4534412 [patent_doc_number] => 07888338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => '7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes' [patent_app_type] => utility [patent_app_number] => 11/295000 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42417 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888338.pdf [firstpage_image] =>[orig_patent_app_number] => 11295000 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/295000
7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes Dec 5, 2005 Issued
Array ( [id] => 4652259 [patent_doc_number] => 20080039515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Arylpyrazoles And Methods Of Using Same For Control Of Insect Pests That Bore Into Trees' [patent_app_type] => utility [patent_app_number] => 11/791899 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11079 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039515.pdf [firstpage_image] =>[orig_patent_app_number] => 11791899 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/791899
Arylpyrazoles And Methods Of Using Same For Control Of Insect Pests That Bore Into Trees Nov 30, 2005 Abandoned
Array ( [id] => 5252830 [patent_doc_number] => 20070134286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals' [patent_app_type] => utility [patent_app_number] => 11/292050 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10088 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134286.pdf [firstpage_image] =>[orig_patent_app_number] => 11292050 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/292050
Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals Nov 30, 2005 Abandoned
Array ( [id] => 5844327 [patent_doc_number] => 20060122117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Method of treating retinopathies and disorders associated with blood vessel loss' [patent_app_type] => utility [patent_app_number] => 11/287152 [patent_app_country] => US [patent_app_date] => 2005-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8066 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122117.pdf [firstpage_image] =>[orig_patent_app_number] => 11287152 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/287152
Method of treating retinopathies and disorders associated with blood vessel loss Nov 24, 2005 Abandoned
Array ( [id] => 5721479 [patent_doc_number] => 20060074255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => '3-Methyl-20-epi-vitamin D derivatives' [patent_app_type] => utility [patent_app_number] => 11/282643 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3591 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074255.pdf [firstpage_image] =>[orig_patent_app_number] => 11282643 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/282643
3-Methyl-20-epi-vitamin D derivatives Nov 20, 2005 Abandoned
Array ( [id] => 5614424 [patent_doc_number] => 20060116352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => '2alpha-Methyl and 2beta-methyl analogs of 19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and their uses' [patent_app_type] => utility [patent_app_number] => 11/283124 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10342 [patent_no_of_claims] => 151 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116352.pdf [firstpage_image] =>[orig_patent_app_number] => 11283124 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/283124
2α-Methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses Nov 17, 2005 Issued
Array ( [id] => 5844401 [patent_doc_number] => 20060122157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => '2-Methylene-18,19-dinor-1alpha-hydroxy-homopregnacalciferol and its uses' [patent_app_type] => utility [patent_app_number] => 11/283222 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7886 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122157.pdf [firstpage_image] =>[orig_patent_app_number] => 11283222 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/283222
2-Methylene-18,19-dinor-1α-hydroxy-homopregnacalciferol and its uses Nov 17, 2005 Issued
Array ( [id] => 5748389 [patent_doc_number] => 20060111321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => '2-Methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses' [patent_app_type] => utility [patent_app_number] => 11/283125 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7752 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111321.pdf [firstpage_image] =>[orig_patent_app_number] => 11283125 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/283125
2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses Nov 17, 2005 Issued
Array ( [id] => 5614423 [patent_doc_number] => 20060116351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => '17,20(Z)-dehydro vitamin D analogs and their uses' [patent_app_type] => utility [patent_app_number] => 11/283090 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11469 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116351.pdf [firstpage_image] =>[orig_patent_app_number] => 11283090 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/283090
17,20(Z)-dehydro vitamin D analogs and their uses Nov 17, 2005 Issued
Array ( [id] => 8294450 [patent_doc_number] => 08222235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => '2-methylene-19-nor-(20R)-1α-hydroxy-bishomopregnacalciferol' [patent_app_type] => utility [patent_app_number] => 11/282972 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5841 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11282972 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/282972
2-methylene-19-nor-(20R)-1α-hydroxy-bishomopregnacalciferol Nov 17, 2005 Issued
Array ( [id] => 5632289 [patent_doc_number] => 20060148759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => '2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses' [patent_app_type] => utility [patent_app_number] => 11/283261 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6267 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148759.pdf [firstpage_image] =>[orig_patent_app_number] => 11283261 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/283261
2α-methyl-19-nor-1α-hydroxy-homopregnacalciferol and its uses Nov 17, 2005 Issued
Array ( [id] => 8006183 [patent_doc_number] => 08084492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Benzofuran compound and pharmaceutical composition containing the same' [patent_app_type] => utility [patent_app_number] => 11/791026 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7816 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084492.pdf [firstpage_image] =>[orig_patent_app_number] => 11791026 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/791026
Benzofuran compound and pharmaceutical composition containing the same Nov 17, 2005 Issued
Array ( [id] => 5650063 [patent_doc_number] => 20060135798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => '2-Methylene-19-nor-(20S)-1alpha-hydroxy-trishomopregnacalciferol' [patent_app_type] => utility [patent_app_number] => 11/282304 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5834 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135798.pdf [firstpage_image] =>[orig_patent_app_number] => 11282304 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/282304
2-methylene-19-nor-(20S)-1α-hydroxy-trishomopregnacalciferol Nov 17, 2005 Issued
Array ( [id] => 5650065 [patent_doc_number] => 20060135800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => '2-Methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol' [patent_app_type] => utility [patent_app_number] => 11/283541 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5711 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135800.pdf [firstpage_image] =>[orig_patent_app_number] => 11283541 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/283541
2-methylene-19,21-dinor-1α-hydroxy-bishomopregnacalciferol Nov 17, 2005 Issued
Array ( [id] => 460041 [patent_doc_number] => 07241752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => '17,20(E)-dehydro vitamin D analogs and their uses' [patent_app_type] => utility [patent_app_number] => 11/283291 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11285 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241752.pdf [firstpage_image] =>[orig_patent_app_number] => 11283291 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/283291
17,20(E)-dehydro vitamin D analogs and their uses Nov 17, 2005 Issued
Array ( [id] => 5596851 [patent_doc_number] => 20060160769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => '2alpha-methyl-19-nor-(20S)-1alpha-hydroxy-bishomopregnacalciferol and its uses' [patent_app_type] => utility [patent_app_number] => 11/283163 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5685 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160769.pdf [firstpage_image] =>[orig_patent_app_number] => 11283163 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/283163
2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses Nov 17, 2005 Issued
Menu